Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients - ANTHICUS

Study identifier:SRP-HB-MER-2005/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS)

Medical condition

Infection in ICU

Phase

Healthy volunteers

None

Study drug

Sex

Unmapped

Actual Enrollment

500

Study type

Observational

Age

None - None

Date

Study Start Date: 01 Feb 2006

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1134&filename=CSR-SRP-HB-MER-2005-1.pdf
Download
CSR-SRP-HB-MER-2005-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Belgium Clinical Study

+3223704898

veronique.duquenne@astrazeneca.com

Investigators

Principal Investigator

Pr Vogelaers

UZ Gents